News Vir awarded $1 billion multi-year BARDA influenza contract The US Government’s Biomedical Advanced Research and Development Authority (BARDA) has made an
News Astellas places $2bn+ bet on AviadoBio dementia gene therapy Astellas has added another gene therapy to its pipeline, taking an option on a clinical-stage candidate for a rare genetic form of dementia from UK biotech AviadoBio for around $50 million.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
